SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-196360
Filing Date
2020-07-21
Accepted
2020-07-21 16:35:53
Documents
3
Period of Report
2020-07-21
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d80995d8k.htm 8-K 22954
2 EX-3.1 d80995dex31.htm EX-3.1 49009
3 EX-3.2 d80995dex32.htm EX-3.2 121805
  Complete submission text file 0001193125-20-196360.txt   195043
Mailing Address 134 COOLIDGE AVENUE 2ND FLOOR WATERTOWN MA 02472
Business Address 134 COOLIDGE AVENUE 2ND FLOOR WATERTOWN MA 02472 617-393-5925
Pandion Therapeutics, Inc. (Filer) CIK: 0001807901 (see all company filings)

IRS No.: 833015614 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39381 | Film No.: 201039210
SIC: 2834 Pharmaceutical Preparations